Report: Opioids settlement won’t fix areas hardest hit

A new analysis finds that money from a tentative settlement with OxyContin maker Purdue Pharma will be “no more than a stopgap” for state and local governments struggling to combat the opioid epidemic. Purdue became the first company being sued over the toll of opioids to reach a tentative nationwide settlement. If approved, it could be worth up to $12 […]

Read more

Chronic pain patients increasingly struggling to access opioid medications in southern Alberta

A representative from HELP_Alberta, an advocacy group for chronic pain sufferers in the province, is raising concerns about accessibility to medications that manage the day-to-day physical suffering of those dealing with pain. “As they lose their medication, they lose their life in all kinds of ways,” said Penny Kowalchuk, the southern Alberta representative for HELP_Alberta. Related Chronic pain patients respond […]

Read more

The ‘fool’ that fentanyl made into a millionaire

The photo that flashed onto the courtroom screen showed a young man dead on his bedroom floor, bare feet poking from the cuffs of his rolled up jeans. Lurking on a trash can at the edge of the picture was what prosecutors said delivered this death: an ordinary, U.S. Postal Service envelope. It had arrived with 10 round, blue pills […]

Read more

Physicians more likely to prescribe opioids later in the day

It’s only human that decision-making changes when people are rushed. Researchers at the University of Minnesota and Harvard University conducted the first study in the United States to examine this phenomenon—using a national source of electronic health records—in primary care physicians when they decide whether to prescribe opioid painkillers. The findings were recently published in JAMA Network Open. Researchers looked […]

Read more

Sacklers vs. States: Settlement Talks Stumble Over Foreign Business

Purdue Pharma’s negotiations to settle thousands of lawsuits over the company’s role in the opioids crisis have turned into a standoff between members of the Sackler family, who own the company, and a group of state attorneys general over how much the family should pay and whether it can continue selling drugs abroad. The Sacklers are deep in negotiations that, […]

Read more

Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal

The Sackler family would give up ownership of Purdue Pharma, the company blamed for much of the opioid epidemic, and pay $3 billion of their own money under terms of a settlement proposal to resolve thousands of federal and state lawsuits, according to a person familiar with the negotiations. The discussions have been going on for months as Purdue and […]

Read more

Johnson & Johnson’s Brand Falters Over Its Role in the Opioid Crisis

In the 1980s, Johnson & Johnson needed a reliable supply of opium for a popular product, Tylenol with codeine. So the health care conglomerate, better known for baby shampoo and Band-Aids, bought a business that grew and processed opium poppies in faraway Tasmania, off the coast of Australia. By 2015, at the height of the nation’s opioid epidemic, Johnson & […]

Read more

Audit: Hospitals put Native Americans at risk with opioids

Government hospitals placed Native American patients at increased risk for opioid abuse and overdoses, failing to follow their own protocols for prescribing and dispensing the drugs, according to a federal audit released Monday. The report by the U.S. Department of Health and Human Services’ Office of Inspector General doesn’t draw any conclusions about actual abuse or overdoses. But it said […]

Read more

Data shows flood of opioids across US, many of them generics

The maker of OxyContin has been cast as the chief villain in the nation’s opioid crisis. But newly released government figures suggest Purdue Pharma had plenty of help in flooding the U.S. with billions of pills even as overdose deaths were accelerating. Records kept by the federal Drug Enforcement Administration show that 76 billion oxycodone and hydrocodone pills—the vast majority […]

Read more

Insys, the Opioid Drug Maker, Files for Bankruptcy

The opioid manufacturer Insys Therapeutics filed for bankruptcy protection Monday, days after agreeing to pay $225 million to settle a federal investigation into the marketing practices for its powerful fentanyl painkiller. The company said it would continue operating while it comes up with a plan to pay its creditors, including the Justice Department, under Chapter 11 of the federal bankruptcy […]

Read more
1 2